Jaguar Gene Therapy
David Greenwald, Ph.D., focuses on early-stage biotechnology investments and supports Deerfield private portfolio companies corporate strategy and business development.
This person is not in the org chart
This person is not in any offices
Jaguar Gene Therapy
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. Led by the former AveXis leadership team and backed by Deerfield Management, a healthcare-specific investment firm, Jaguar brings streamlined R&D, manufacturing and clinical operations to accelerate development and potential approval of therapies for severe genetic diseases.